| ΔE | Color difference against control samples, in the L*C*h* color space |
| a* | Redness color change in the CIEL*a*b* space |
| ABTS | 2,2-azino-bis(ethylbenzothiazoline-6-sulfonic acid) |
| aw | Activity of water |
| ANC | Anthocyanins |
| b* | Yellowness color change in the CIEL*a*b* space |
| C* | Chroma |
| C3G | Cyanidin-3-O-glucoside |
| C3G-Mal | Cyanidin-3-(6′-malonylglucoside) |
| Caco-2 | Human colorectal adenocarcinoma cells |
| cfu | Colony forming units |
| D3G | Delphinidin-3-O-glucoside |
| DM | Dry matter |
| DPPH | 2,2-diphenyl-1-picrylhydrazyl |
| EC3G/L | Equivalents of C3G |
| EC50 | Half-maximal effective concentration |
| EF | Electric field |
| EGCG | Epigallocatechin gallate |
| FRAP | Ferric ion reducing antioxidant power |
| FT-IR | Fourier Transform Infrared |
| GAE | Gallic acid equivalents |
| GC | Gas chromatography |
| GRAS | Generally recognized as safe |
| HepG2 | Human hepatocellular carcinoma cells |
| HHPE | High hydrostatic pressure extraction |
| HPE | High-pressure-assisted extraction |
| IAT | Inlet air temperature |
| L* | Luminosity or lightness in the CIEL*a*b* space |
| MBC | Minimum bactericidal concentration |
| MCF-7 | Human mammary gland/breast adenocarcinoma cells (derived from metastatic site) |
| MDA | Malonaldehyde |
| MDA-MB-231 | Triple negative human mammary gland/breast adenocarcinoma cells |
| MIC | Minimum inhibitory concentration |
| OAT | Outlet air temperature |
| OH | Ohmic heating |
| P3G | Peonidin-3-(6′-malonylglucoside) |
| P3G-Mal | Pelargonidin-3-(6′-malonylglucoside) |
| PEF | Pulsed electric fields |
| Pr3G | Pelargonidin-3-O-glucoside |
| RSA | Radical scavenging activity (%) |
| SC-CO2 | Supercritical carbon dioxide |
| SFC | Supercritical fluid chromatography |
| SFE | Supercritical fluid extraction |
| TAC | Total anthocyanin content |
| TBARS | Thiobarbituric acid reactive substances |
| TEAC | Trolox equivalent antioxidant capacity |
| TPC | Total phenolic compounds |
| VPR | Vine-pruning residues |
| XR | X-ray |